Maynard Um
-
-
-
-
-
-
-
Cytokinetics gets European approval for heart drug MYQORZO
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $84 at Needham
-
-
-
-
-
-
-
Cytokinetics receives China approval for heart drug MYQORZO
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Cytokinetics (CYTK) at Overweight Post Model Update
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)
-
-
-
-
-
-
-
Truist: 'We Remain Buyers of Cytokinetics (CYTK)'
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Cytokinetics (CYTK)
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

